Products
18317 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nokia Constant Leverage with ISIN code: CH1119067226 | Nokia | Constant Leverage | Long | ― | 3.926 | 0.52 | 0.010 | 0.53 | 1 | -1.89% | -3.70% | 36.84% | 6 May. 2022 | |
| Nokia Constant Leverage with ISIN code: CH1450969105 | Nokia | Constant Leverage | Long | ― | 3.926 | 15.3 | 0.120 | 15.42 | 1 | -0.78% | -4.97% | ― | 21 Aug. 2025 | |
| Nokia Constant Leverage with ISIN code: CH1450969097 | Nokia | Constant Leverage | Short | ― | 3.926 | 5.45 | 0.030 | 5.48 | 1 | -1.80% | 0.00% | ― | 21 Aug. 2025 | |
| Nokia Constant Leverage with ISIN code: CH1235293169 | Nokia | Constant Leverage | Short | ― | 3.926 | 1.42 | 0.010 | 1.43 | 1 | -1.39% | 0.00% | -37.44% | 30 Nov. 2022 | |
| Novartis Constant Leverage with ISIN code: CH1423416671 | Novartis | Constant Leverage | Long | ― | 101.78 | 17.16 | 0.350 | 17.51 | 1 | 2.51% | -24.67% | 56.28% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587305 | Novartis | Constant Leverage | Long | ― | 101.78 | 0.97 | 0.030 | 1 | 1 | 0.00% | -21.77% | 42.65% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587271 | Novartis | Constant Leverage | Long | ― | 101.78 | 10.24 | 0.090 | 10.33 | 1 | 0.79% | -8.33% | 19.07% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587289 | Novartis | Constant Leverage | Long | ― | 101.78 | 6.65 | 0.080 | 6.73 | 1 | 1.22% | -12.50% | 28.38% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587297 | Novartis | Constant Leverage | Long | ― | 101.78 | 3.1 | 0.050 | 3.15 | 1 | 1.31% | -16.67% | 37.17% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587255 | Novartis | Constant Leverage | Short | ― | 101.78 | 0.64 | 0.030 | 0.67 | 1 | -7.25% | 4.92% | -31.91% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587263 | Novartis | Constant Leverage | Short | ― | 101.78 | 2.05 | 0.030 | 2.08 | 1 | -3.30% | 5.13% | -21.76% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416655 | Novartis | Constant Leverage | Short | ― | 101.78 | 1.11 | 0.030 | 1.14 | 1 | -8.26% | 15.63% | -55.95% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1423416663 | Novartis | Constant Leverage | Short | ― | 101.78 | 1.75 | 0.040 | 1.79 | 1 | -7.41% | 12.90% | -48.83% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587248 | Novartis | Constant Leverage | Short | ― | 101.78 | 0.16 | 0.030 | 0.19 | 1 | -15.79% | -5.88% | -44.83% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1276587339 | Novo Nordisk | Constant Leverage | Long | ― | 345.561 | 0.021 | ― | ― | 1 | 75.00% | 50.00% | 110.00% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968495 | Novo Nordisk | Constant Leverage | Long | ― | 345.561 | 9.4 | 0.090 | 9.49 | 1 | -8.02% | -38.16% | ― | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968487 | Novo Nordisk | Constant Leverage | Long | ― | 345.561 | 10.71 | 0.070 | 10.78 | 1 | -5.64% | -28.60% | ― | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450967372 | Novo Nordisk | Constant Leverage | Long | ― | 345.561 | 0.003 | ― | ― | 1 | 200.00% | 200.00% | 200.00% | 9 Jul. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993042 | Novo Nordisk | Constant Leverage | Long | ― | 345.561 | 0.01 | ― | ― | 1 | 900.00% | 900.00% | 900.00% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993299 | Novo Nordisk | Constant Leverage | Long | ― | 345.561 | 0.009 | ― | ― | 1 | 800.00% | 800.00% | 800.00% | 11 Mar. 2024 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.